Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001906324-25-000151
Filing Date
2025-08-06
Accepted
2025-08-05 18:11:59
Documents
79
Period of Report
2025-06-29

Document Format Files

Seq Description Document Type Size
1 10-Q qdel-20250629.htm   iXBRL 10-Q 1334377
2 EX-31.1 ex3116292025.htm EX-31.1 9546
3 EX-31.2 ex3126292025.htm EX-31.2 9652
4 EX-32.1 ex3216292025.htm EX-32.1 5495
  Complete submission text file 0001906324-25-000151.txt   7617816

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qdel-20250629.xsd EX-101.SCH 44271
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT qdel-20250629_cal.xml EX-101.CAL 91833
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT qdel-20250629_def.xml EX-101.DEF 201299
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qdel-20250629_lab.xml EX-101.LAB 584026
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qdel-20250629_pre.xml EX-101.PRE 427833
82 EXTRACTED XBRL INSTANCE DOCUMENT qdel-20250629_htm.xml XML 1435688
Mailing Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Business Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 (858) 552-1100
QuidelOrtho Corp (Filer) CIK: 0001906324 (see all company filings)

EIN.: 874496285 | Fiscal Year End: 0101
Type: 10-Q | Act: 34 | File No.: 001-41409 | Film No.: 251186518
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)